This PDF file includes: Table S1 . Baboon raw data. Variants of 1B7 were compared by (A) nonreducing and (B) reducing SDS-PAGE. Purified antibodies with (C) human or (D) mouse constant regions were compared for binding to a PTx coated plate by ELISA with detection by anti-human Fc or anti-mouse Fc antibodies, respectively. In (C), the average of duplicate hu1B7 data are in blue triangles, hu1B7-YTE are in green diamonds, hu1B7-N297A are in purple circles, and no primary control data are in grey squares. For (D) the average of quadruplicate rch1B7 data are in blue circles, m1B7 data are in yellow triangles, and no primary control data are in grey squares. Fits are shown as lines in the color of the data. . Dosing hu1B7 in the mouse challenge model. Four-week-old Balb/c mice were administered antibody or PBS intraperitoneally in a 200 l volume two hours prior to infection with 10 7 cfu B. pertussis strain D420. Infection severity was assessed after seven days by (A) CD45+ leukocytosis (WBC) and (B) B. pertussis lung colonization (no colonies were recovered for PBS-treated, uninfected mice). Data shown were pooled from three separate experiments, each including uninfected controls and infected controls treated with PBS or 10 g hu1B7, with each group comprising 4-6 mice. Mean and standard deviation for each treatment are shown in red; s ignificance was determined by two-way ANOVA with Tukey HSD with * p<0.05, ** p<0.01, **** p<0.0001. Anti-PTx antibody titers were measured for each baboon (left vertical axis, black line and circles) and WBC count was determined for each point (right vertical axis, grey line and square s). In each data set, the day the baboon was infected with B. pertussis is identified by a red marker. . In each data set, the day the baboon was infected with B. pertussis is identified by a red marker.
Fig. S6. Pearson correlation of antidrug antibody titers and anti -PTx titers.
A strong correlation exists between anti-PTx antibody titer seven days after infection and day of infection anti-drug antibody titer (Pearson's correlation of -0.95 for hu1B7 treated animals). Data from animals treated with hu1B7 is shown in blue triangles and data from animals treated with hu1B7-YTE is shown in green diamonds.
Fig. S7. Presence of 1B7 does not interfere with anti-PTx responses due to vaccination.
Mice were administered 20 g r-ch1B7 (human binding site + mouse Fc), immunized 24 hrs later with 1/50 th human dose and boosted four weeks later. The (A) anti-Fha and (B) anti-PTx serum titers were monitored weekly for six weeks. Control mice included those only administered r-ch1B7 to monitor the titer of this specific antibody versus the polyclonal endogenous mouse response. No differences were observed in titers of immunized mice immunized based on the presence of r-ch1B7. Shown are data for individual mice; use of purified r-ch1B7 or a mouse anti-Fha antibody as a reference allowed for quantification of serum antibody titers and standardization between plates. 
